Indraprastha Medical Corporation Limited (INDRAMEDCO.BO)
- Previous Close
265.25 - Open
266.45 - Bid 262.55 x --
- Ask 264.00 x --
- Day's Range
261.00 - 273.95 - 52 Week Range
80.00 - 282.45 - Volume
61,524 - Avg. Volume
67,001 - Market Cap (intraday)
24.046B - Beta (5Y Monthly) 0.74
- PE Ratio (TTM)
21.33 - EPS (TTM)
12.30 - Earnings Date Feb 6, 2024
- Forward Dividend & Yield 3.00 (1.14%)
- Ex-Dividend Date Sep 15, 2023
- 1y Target Est
--
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, endovascular surgery, endocrinology, ENT, fetal medicine, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, ophthalmology, pediatric sciences, urology, and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neurology/neurosurgery, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, sleep medicine and clinical care, and transfusion medicine. The company was founded in 1983 and is based in New Delhi, India.
www.delhi.apollohospitals.com2,947
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: INDRAMEDCO.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INDRAMEDCO.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INDRAMEDCO.BO
Valuation Measures
Market Cap
24.05B
Enterprise Value
21.96B
Trailing P/E
21.34
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.05
Price/Book (mrq)
5.80
Enterprise Value/Revenue
1.88
Enterprise Value/EBITDA
11.49
Financial Highlights
Profitability and Income Statement
Profit Margin
9.35%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
12.04B
Net Income Avi to Common (ttm)
1.13B
Diluted EPS (ttm)
12.30
Balance Sheet and Cash Flow
Total Cash (mrq)
2.07B
Total Debt/Equity (mrq)
1.13%
Levered Free Cash Flow (ttm)
--
Company Insights: INDRAMEDCO.BO
INDRAMEDCO.BO does not have Company Insights